GI June 2007 - Latest Updates from ASCO

We would like to thank Drs Scott Berry, Chris Booth & Phil Bedard for providing us with the latest oncology GI meeting updates
 

ASCO 2007 Conference Updates

Oxaliplatin/5FU/LV in adjuvant colon cancer: Updated efficacy results of the MOSAIC trial, including survival, with a median follow-up of six years

Peri-operative FOLFOX4 chemotherapy and surgery for resectable liver metastases from colorectal cancer

Sorafenib Improves Survival in Hepatocellular Carcinoma: Results of a Phase III Randomized, Placebo-Controlled Trial

The CRYSTAL trial: Efficacy and safety of irinotecan and 5-FU/FA with and without cetuximab in the first-line treatment of metastatic colorectal cancer

Sequential compared to combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (ACC): A Dutch Colorectal Cancer group (DCCG) phase III study

CAPEOX vs. FOLFOX4 +/- Bevacizumab: survival results from NO16966, a randomized phase III trial of first-line treatment for patients with metastatic colorectal cancer (MCRC)

OPTIMOX2, a large randomized phase II study of maintenance therapy or chemotherapy-free intervals (CFI) after FOLFOX in patients with metastatic colorectal cancer (MRC)